(Q74067312)
Statements
Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan (English)
Emerson DL
Bendele R
Brown E
Chiang S
Desjardins JP
Dihel LC
Gill SC
Hamilton M
LeRay JD
Moon-McDermott L
Moynihan K
Richardson FC
Tomkinson B
Luzzio MJ